Analysis of gene expression identifies candidate markers and pathways in pre-eclampsia

Area of Science:

• Genomics
• Bioinformatics
• Molecular Biology

Background:

• Pre-eclampsia is a severe multisystem disorder with significant global maternal and fetal morbidity and mortality.
• Limited understanding of pre-eclampsia's molecular mechanisms hinders effective diagnosis and treatment.

Purpose of the Study:

• To screen key molecular regulators and pathways involved in early-onset pre-eclampsia using bioinformatics.
• To identify potential diagnostic and therapeutic targets for pre-eclampsia.

Main Methods:

• Downloaded and analyzed gene expression profiling dataset GSE44711 from the Gene Expression Omnibus database.
• Identified differentially expressed genes (DEGs) using limma, followed by Gene Ontology and KEGG pathway analysis.
• Constructed a protein-protein interaction network using the Search Tool for the Retrieval of Interacting Genes database.

Main Results:

• Identified 192 DEGs (106 upregulated, 86 downregulated) between early-onset pre-eclampsia and control placentas.
• Noted Proteoglycan 2 and podoplanin as the most significantly up- and downregulated genes, respectively.
• Associated three pathways (arginine and proline metabolism, focal adhesion, extracellular matrix-receptor interaction) with pre-eclampsia, involving genes like COL1A1 and FN1.

Conclusions:

• Identified potential candidate genes and pathways for pre-eclampsia diagnosis and therapy.
• Highlights the role of arginine and proline metabolism, focal adhesion, and extracellular matrix-receptor interaction in pre-eclampsia pathogenesis.
• Suggests further investigation into identified genes and pathways for clinical application in managing pre-eclampsia.